NCT00037765View on ClinicalTrials.gov

Gene Modifiers of Cystic Fibrosis Lung Disease

Active, not recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Cystic FibrosisLung Diseases
Trial Locations (1)

27599-7248

Marsico Lung Institute, Chapel Hill

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of North Carolina, Chapel Hill

OTHER